The incidence and implications of anti-heparin-platelet factor 4 antibody formation in a pediatric cardiac surgical population

Anesthesia and Analgesia

Volumn 107, Issue 2, 2008, Pages 371-378

  Mullen, Mary P ^a,b   Wessel, David L ^a,b   Thomas, Kristen C ^a   Gauvreau, Kimberlee ^a,c   Neufeld, Ellis J ^a,b   McGowan, Francis X ^a,b   Dinardo, James A ^a,b  

^a BOSTON CHILDREN S HOSPITAL   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICOAGULANT AGENT; APROTININ; HEPARIN; IMMUNOGLOBULIN A ANTIBODY; IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN M ANTIBODY; THROMBOCYTE ANTIBODY; THROMBOCYTE FACTOR 4; THROMBOCYTE FACTOR 4 ANTIBODY; TRANEXAMIC ACID; UNCLASSIFIED DRUG; IMMUNOGLOBULIN;

ADOLESCENT; ADULT; ARTICLE; BLOOD SAMPLING; CHILD; CONTINUOUS INFUSION; CONTROLLED STUDY; FEMALE; HEART SURGERY; HEPARIN INDUCED THROMBOCYTOPENIA; HUMAN; INCIDENCE; LOADING DRUG DOSE; MAJOR CLINICAL STUDY; MALE; NEWBORN; PEDIATRICS; POSTOPERATIVE PERIOD; PREOPERATIVE PERIOD; PRIORITY JOURNAL; PROSPECTIVE STUDY; REOPERATION; SEROCONVERSION; THROMBOCYTOPENIA; ANTIBODY PRODUCTION; BLOOD; CHEMICALLY INDUCED DISORDER; HEART CATHETERIZATION; IMMUNOLOGY; INFANT;

ANTIBODY FORMATION; ANTICOAGULANTS; CARDIAC SURGICAL PROCEDURES; FEMALE; HEART CATHETERIZATION; HEPARIN; HUMANS; IMMUNOGLOBULINS; INFANT; INFANT, NEWBORN; MALE; PLATELET FACTOR 4; REOPERATION; THROMBOCYTOPENIA;

EID: 49949099850     PISSN: 00032999     EISSN: None     Source Type: Journal    
DOI: 10.1213/ane.0b013e3181734604     Document Type: Article

References (29)

1. Risch L, Huber AR, Schmugge M. Diagnosis and treatment of heparin-induced thrombocytopenia in neonates and children. Thromb Res 2006;118:123-35
2. Hanson SJ, Punzalan RC, Ghanayem N, Havens P. Prevalence of heparin-dependent platelet antibodies in children after cardiopulmonary bypass. Pediatr Crit Care Med 2007;8:358-61
3. Amiral J, Bridey F, Wolf M, Boyer-Neumann C, Fressinaud E, Vissac AM, Peynaud-Debayle E, Dreyfus M, Meyer D. Antibodies to macromolecular platelet factor 4-heparin complexes in heparininduced thrombocytopenia: a study of 44 cases. Thromb Haemost 1995;73:21-8
4. Warkentin TE. Heparin-induced thrombocytopenia: pathogenesis and management. Br J Haematol 2003;121:535-55
5. Warkentin TE, Sheppard JA, Horsewood P, Simpson PJ, Moore JC, Kelton JG. Impact of the patient population on the risk for heparin-induced thrombocytopenia. Blood 2000;96:1703-8
6. Fohlen-Walter A, De Maistre E, Mulot A, Marchand-Arvier M, Lecompte T. Does negative heparin-platelet factor 4 enzymelinked immunosorbent assay effectively exclude heparininduced thrombocytopenia? J Thromb Haemost 2003;1:1844-5
7. Amiral J, Marfaing-Koka A, Wolf M, Alessi MC, Tardy B, Boyer-Neumann C, Vissac AM, Fressinaud E, Poncz M, Meyer D. Presence of autoantibodies to interleukin-8 or neutrophilactivating peptide-2 in patients with heparin-associated thrombocytopenia. Blood 1996;88:410-6
8. Regnault V, de Maistre E, Carteaux JP, Gruel Y, Nguyen P, Tardy B, Lecompte T. Platelet activation induced by human antibodies to interleukin-8. Blood 2003;101:1419-21
9. Harenberg J, Wang LC, Hoffmann U, Huhle G, Feuring M. Laboratory diagnosis of heparin-induced thrombocytopenia type II after clearance of platelet factor 4/heparin complex. J Lab Clin Med 2001;137:408-13
10. Warkentin TE, Heddle NM. Laboratory diagnosis of immune heparin-induced thrombocytopenia. Curr Hematol Rep 2003;2: 148-57
11. Warkentin TE, Greinacher A. Heparin-induced thrombocytopenia and cardiac surgery. Ann Thorac Surg 2003;76:2121-31
12. Bauer TL, Arepally G, Konkle BA, Mestichelli B, Shapiro SS, Cines DB, Poncz M, McNulty S, Amiral J, Hauck WW, Edie RN, Mannion JD. Prevalence of heparin-associated antibodies without thrombosis in patients undergoing cardiopulmonary bypass surgery. Circulation 1997;95:1242-6
13. Bennett-Guerrero E, Slaughter TF, White WD, Welsby IJ, Greenberg CS, El-Moalem H, Ortel TL. Preoperative anti- PF4/heparin antibody level predicts adverse outcome after cardiac surgery. J Thorac Cardiovasc Surg 2005;130:1567-72
14. Kress DC, Aronson S, McDonald ML, Malik MI, Divgi AB, Tector AJ, Downey FX III, Anderson AJ, Stone M, Clancy C. Positive heparin-platelet factor 4 antibody complex and cardiac surgical outcomes. Ann Thorac Surg 2007;83:1737-43
15. Klenner AF, Fusch C, Rakow A, Kadow I, Beyersdorff E, Eichler P, Wander K, Lietz T, Greinacher A. Benefit and risk of heparin for maintaining peripheral venous catheters in neonates: a placebo-controlled trial. J Pediatr 2003;143:741-5
16. Amiral J, Vissac AM. Generation and pathogenicity of antiplatelet factor 4 antibodies: diagnostic implications. Clin Appl Thromb Hemost 1999;5(Suppl 1):S28-31
17. Rauova L, Zhai L, Kowalska MA, Arepally GM, Cines DB, Poncz M. Role of platelet surface PF4 antigenic complexes in heparin-induced thrombocytopenia pathogenesis: diagnostic and therapeutic implications. Blood 2006;107:2346-53
18. Severin T, Sutor AH. Heparin-induced thrombocytopenia in pediatrics. Semin Thromb Hemost 2001;27:293-9
19. Spadone D, Clark F, James E, Laster J, Hoch J, Silver D. Heparin-induced thrombocytopenia in the newborn. J Vasc Surg 1992;15:306 -11; discussion 11-12
20. Butler TJ, Sodoma LJ, Doski JJ, Cheu HW, Berg ST, Stokes GN, Lancaster KJ. Heparin-associated thrombocytopenia and thrombosis as the cause of a fatal thrombus on extracorporeal membrane oxygenation. J Pediatr Surg 1997;32:768-71
21. Nguyen TN, Gal P, Ransom JL, Carlos R. Lepirudin use in a neonate with heparin-induced thrombocytopenia. Ann Pharmacother 2003;37:229-33
22. Ranze O, Ranze P, Magnani HN, Greinacher A. Heparininduced thrombocytopenia in paediatric patients-a review of the literature and a new case treated with danaparoid sodium. Eur J Pediatr 1999;158(Suppl 3):S130-3
23. Newall F, Barnes C, Ignjatovic V, Monagle P. Heparin-induced thrombocytopenia in children. J Paediatr Child Health 2003;39: 289-92
24. Risch L, Fischer JE, Schmugge M, Huber AR. Association of anti-heparin platelet factor 4 antibody levels and thrombosis in pediatric intensive care patients without thrombocytopenia. Blood Coagul Fibrinolysis 2003;14:113-6
25. Schmugge M, Risch L, Huber AR, Benn A, Fischer JE. Heparininduced thrombocytopenia-associated thrombosis in pediatric intensive care patients. Pediatrics 2002;109:E10
26. Hong AP, Cook DJ, Sigouin CS, Warkentin TE. Central venous catheters and upper-extremity deep-vein thrombosis complicating immune heparin-induced thrombocytopenia. Blood 2003;101: 3049-51
27. van Ommen CH, Heijboer H, Buller HR, Hirasing RA, Heijmans HS, Peters M. Venous thromboembolism in childhood: a prospective two-year registry in The Netherlands. J Pediatr 2001;139:676-81
28. van Ommen CH, Peters M. Venous thromboembolic disease in childhood. Semin Thromb Hemost 2003;29:391-404
29. Alsoufi B, Boshkov LK, Kirby A, Ibsen L, Dower N, Shen I, Ungerleider R. Heparin-induced thrombocytopenia (HIT) in pediatric cardiac surgery: an emerging cause of morbidity and mortality. Semin Thorac Cardiovasc Surg Pediatr Card Surg Annu 2004;7:155-71